BioSpace News Archive

As per Precedence Research, the homecare diagnostics & therapeutics market size is projected to reach US$ 365.35 billion by 2029 and expanding growth at a CAGR of 8% from 2021 to 2030.

As per Precedence Research, the global life science reagents market size is expected to hit US$ 80.86 billion by 2029 with a notable CAGR of 8.3% during the forecast period 2021 to 2030.

As per Precedence Research, the global life science tools market is poised to grow at a CAGR of 8.5% from 2020 to 2027 and to reach valuation US$ 95.68 billion by 2027.

The medical oxygen concentrator’s market growth is estimated to reach at a CAGR of 12.8% during the forecast period and to reach valuation US$ 4.99 billion by 2030.

The PACS and RIS market size is expected to worth around US$ 5.96 billion by 2029 and is growing at a CAGR of 7.6% over the forecast period 2021 to 2030.

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced it is a 2022 Edison Award Finalist for its iTind™ Procedure, which is nominated within the Science and Medical category for Medical Treatments.

Viva Biotech Holdings announced that during the year ended December 31, 2021, the revenue of the Group increased significantly to RMB2,104.1 million from RMB697.0 million for the corresponding period last year, representing a YoY increase of approximately 201.9%, gross profit increased substantially from RMB304.9 million for the corresponding period last year to RMB651.0 million, representing a YoY increase of 113.5%.

The U.S. Food and Drug Administration announced it is requesting a total budget of $8.4 billion as part of the President’s fiscal year 2023 budget – a nearly 34% increase over the agency’s FY 2022 appropriated funding level for investments in critical public health modernization, core food safety and medical product safety programs and other vital public health infrastructure.

Chandra Ramanathan, executive-in-residence at Mass General Brigham and a biopharmaceutical executive with extensive experience translating scientific ideas into treatment options and access for patients with high medical needs, has joined McLean Hospital’s Board of Trustees.

The blood pressure monitoring devices market size is expected to be worth around US$ 5.50 billion by 2030 from valued at US$ 3.28 billion in 2020 and is poised to grow at a CAGR of 12.4% from 2021 to 2030.